• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Fraud conviction stands, but $13m penalty to be reevaluated for ex-Heart Tronics exec Stein

Fraud conviction stands, but $13m penalty to be reevaluated for ex-Heart Tronics exec Stein

January 19, 2017 By Fink Densford

Judge blocks dialysis aid ruleA federal appeals court this week ruled that a $13.2 million penalty against former Heart Tronics CEO Mitchell Stein should be reevaluated, but upheld an associated fraud conviction.

Stein was convicted in May 2013 of 14 charges of fraudulently inflating share prices for heart monitoring devices maker Signalife, later known as Heart Tronics.

The US Court of Appeals for the 11th Circuit this week upheld the fraud convictions, but vacated the $13.2 million penalty with “instructions to calculate anew the amount of loss,” according to court documents.

Last April, former co-chief exec officer and ex-NFL wide receiver Willie Gault was ordered to pay $206,571 to settle an SEC suit over his role in the inflation scheme.

The fines included a $78,000 civil fine and an additional $101,000 in ill-gotten gains, plus $27,571 in interest. Gault was also banned from being an officer or director of public companies.

A jury in March cleared Gault of intentionally defrauding investors, but found him liable for filing false certifications with the SEC and circumventing the company’s internal controls.

In June 2014, a California District Judge harshly refused Stein’s motion for a retrial, taking offense to the request itself.

Stein had been petitioning for a retrial since at least September 2013, filing several motions, all of which were summarily dismissed by Judge Kenneth Marra.

“The Court finds these motions not only to be baseless, but also offensive,” Marra wrote in his ruling. “There was more than sufficient evidence presented upon which a reasonable jury could find, beyond a reasonable doubt, that Defendant was guilty.”

Marra further denied Stein’s request to compel prosecutors to produce documents and meeting minutes of grand jury proceedings, as well as Stein’s motion for conditional release pending sentencing, according to court documents.

Material from Reuters was used in this report.

Filed Under: Business/Financial News, Legal News Tagged With: Heart Tronics

More recent news

  • Imperative Care has positive stroke treatment study results
  • Medtronic enrolls first patient in study for Onyx liquid embolic system
  • Intuitive demonstrates remote telesurgery capabilities with da Vinci 5
  • BD issues voluntary recall on certain Alaris infusion pump modules
  • CVRx announces Medicare win for Barostim therapy

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy